Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $5,000/year · Income ≤500% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C61 C80.0 C80.1 D07.5 D29.1Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J9023
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 866-316-7263, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Prolia / Jubbonti + biosimilars, Tecentriq, Avastin / biosimilars, Imfinzi.
Status shown as of each fund's last verification.
As of May 2, 2026, the PAN Foundation Prostate cancer fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 866-316-7263.
Up to $5,000/year. Covers drug cost only — administration billed separately
Household income must be ≤500% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.